Endocrine Abstracts

Introduction: The management of prolactinomas, whatever their size, is based on medical treatment with dopamine agonists (DA). The latter allows clinical improvement with efficient control of prolactin secretion and tumor growth. Pituitary surgery or radiotherapy are adjuvant therapies in case of neurologic complication or lack of response to DA.Patients and methods: We conducted a monocentric analytic study of patients followed for confirmed prolactinom...

Introduction: Macroprolactinoma is a rare pathology often considered benign. However, its singularity lies in its potential to become highly invasive, threatening both functional and vital prognosis by infiltrating surrounding structures.Patients and methods: We conducted a monocentric, cross-sectional, analytical study of patients followed for confirmed prolactinoma at the endocrinology-internal medicine and neurosurgery departments of the Fattouma Bour...

Introduction: Prolactinomas are the most commun secreting adenomas of the pituitary gland. They are classified according to their sizes into microprolactinomas (<10mm long axis) and macroprolactinoma (>=10mm long axis). According to studies its prevalence is approximately 3.5-5 for 100000 inhabitants. The diagnosis is made by the blood prolactin assay as well as the pituitary magnetic resonance imaging (MRI) which is the radiological reference exam to evaluate the dime...